{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:51:59Z","timestamp":1792547519273,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170806"],"award-info":[{"award-number":["82170806"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30915"],"award-info":[{"award-number":["2023JJ30915"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515110998"],"award-info":[{"award-number":["2023A1515110998"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02689-z","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T11:30:08Z","timestamp":1755689408000},"page":"81-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and genetic features of older patients with pheochromocytomas and paragangliomas: A multicenter retrospective study"],"prefix":"10.1007","volume":"49","author":[{"given":"Xiaowen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxian","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anze","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0274-4057","authenticated-orcid":false,"given":"Longfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"2689_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/s0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"Lenders JW, Eisenhofer G, Mannelli M, Pacak K (2005) Phaeochromocytoma. Lancet 366:665\u2013675. https:\/\/doi.org\/10.1016\/s0140-6736(05)67139-5","journal-title":"Lancet"},{"key":"2689_CR2","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr., Endocrine S (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:1915\u20131942. https:\/\/doi.org\/10.1210\/jc.2014-1498","journal-title":"J Clin Endocrinol Metab"},{"key":"2689_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1515\/enr-2017-0018","volume":"51","author":"FA Farrugia","year":"2017","unstructured":"Farrugia FA, Martikos G, Tzanetis P, Charalampopoulos A, Misiakos E, Zavras N, Sotiropoulos D (2017) Pheochromocytoma, diagnosis and treatment: review of the literature. Endocr Regul 51:168\u2013181. https:\/\/doi.org\/10.1515\/enr-2017-0018","journal-title":"Endocr Regul"},{"key":"2689_CR4","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM (2016) Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol 175:G1\u2013G34. https:\/\/doi.org\/10.1530\/EJE-16-0467","journal-title":"Eur J Endocrinol"},{"key":"2689_CR5","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1210\/clinem\/dgad401","volume":"109","author":"S Aggarwal","year":"2023","unstructured":"Aggarwal S, Prete A, Chortis V, Asia M, Sutcliffe RP, Arlt W, Ronchi CL, Karavitaki N, Ayuk J, Elhassan YS (2023) Pheochromocytomas most commonly present as adrenal incidentalomas: A large tertiary center experience. J Clin Endocrinol Metab 109:e389\u2013e396. https:\/\/doi.org\/10.1210\/clinem\/dgad401","journal-title":"J Clin Endocrinol Metab"},{"key":"2689_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1530\/EJE-20-0628","volume":"184","author":"AA Leung","year":"2021","unstructured":"Leung AA, Pasieka JL, Hyrcza MD, Pacaud D, Dong Y, Boyd JM, Sadrzadeh H, Kline GA (2021) Epidemiology of pheochromocytoma and paraganglioma: population-based cohort study. Eur J Endocrinol 184:19\u201328. https:\/\/doi.org\/10.1530\/EJE-20-0628","journal-title":"Eur J Endocrinol"},{"key":"2689_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","volume":"51","author":"AMA Berends","year":"2018","unstructured":"Berends AMA, Buitenwerf E, de Krijger RR, Veeger N, van der Horst-Schrivers ANA, Links TP, Kerstens MN (2018) Incidence of pheochromocytoma and sympathetic paraganglioma in the netherlands: A nationwide study and systematic review. Eur J Intern Med 51:68\u201373. https:\/\/doi.org\/10.1016\/j.ejim.2018.01.015","journal-title":"Eur J Intern Med"},{"key":"2689_CR8","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1161\/HYPERTENSIONAHA.124.22753","volume":"81","author":"JB de Freminville","year":"2024","unstructured":"de Freminville JB, Gardini M, Cremer A, Camelli S, Baron S, Bobrie G, Gosse P, Boulestreau R, Gebara N, Doublet J, Dussartre T, Grataloup C, Lorthioir A, Massien C, Madjalian AM, Riancho J, Soulat G, Postel-Vinay N, Azizi M, Rance B, Amar L (2024) Prevalence and risk factors for secondary hypertension in young adults. Hypertension 81:2340\u20132349. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.124.22753","journal-title":"Hypertension"},{"key":"2689_CR9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1210\/jc.2018-01707","volume":"104","author":"LM Gruber","year":"2019","unstructured":"Gruber LM, Hartman RP, Thompson GB, McKenzie TJ, Lyden ML, Dy BM, Young WF, Bancos I (2019) Pheochromocytoma characteristics and behavior differ depending on method of discovery. J Clin Endocrinol Metab 104:1386\u20131393. https:\/\/doi.org\/10.1210\/jc.2018-01707","journal-title":"J Clin Endocrinol Metab"},{"key":"2689_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1210\/jc.2010-1588","volume":"96","author":"G Eisenhofer","year":"2011","unstructured":"Eisenhofer G, Timmers HJ, Lenders JW, Bornstein SR, Tiebel O, Mannelli M, King KS, Vocke CD, Linehan WM, Bratslavsky G, Pacak K (2011) Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J Clin Endocrinol Metab 96:375\u2013384. https:\/\/doi.org\/10.1210\/jc.2010-1588","journal-title":"J Clin Endocrinol Metab"},{"key":"2689_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212056","author":"I Martinez de Lapiscina","year":"2024","unstructured":"Martinez de Lapiscina I, Diego E, Baquero C, Fernandez E, Menendez E, Moure MD, Ruiz de Azua T, Castano L, Valdes N, On Behalf Of The Collaborative Working G (2024) Novel gene variants in a nationwide cohort of patients with pheochromocytoma and paraganglioma. Int J Mol Sci 25. https:\/\/doi.org\/10.3390\/ijms252212056","journal-title":"Int J Mol Sci 25"},{"key":"2689_CR12","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","volume":"38","author":"JWM Lenders","year":"2020","unstructured":"Lenders JWM, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, Pacak K, Crona J, Zelinka T, Mannelli M, Deutschbein T, Timmers H, Castinetti F, Dralle H, Widimsky J, Gimenez-Roqueplo AP, Eisenhofer G (2020) Genetics, diagnosis, management and future directions of research of Phaeochromocytoma and paraganglioma: a position statement and consensus of the working group on endocrine hypertension of the European society of hypertension. J Hypertens 38:1443\u20131456. https:\/\/doi.org\/10.1097\/HJH.0000000000002438","journal-title":"J Hypertens"},{"key":"2689_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41440-019-0339-y","volume":"43","author":"M Parasiliti-Caprino","year":"2020","unstructured":"Parasiliti-Caprino M, Lucatello B, Lopez C, Burrello J, Maletta F, Mistrangelo M, Migliore E, Tassone F, La Grotta A, Pia A, Reimondo G, Giordano R, Giraudo G, Piovesan A, Ciccone G, Deandreis D, Limone P, Orlandi F, Borretta G, Volante M, Mulatero P, Papotti M, Aimaretti G, Terzolo M, Morino M, Pasini B, Veglio F, Ghigo E, Arvat E, Maccario M (2020) Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy. Hypertens Res 43:500\u2013510. https:\/\/doi.org\/10.1038\/s41440-019-0339-y","journal-title":"Hypertens Res"},{"key":"2689_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11070936","author":"D Mamilla","year":"2019","unstructured":"Mamilla D, Araque KA, Brofferio A, Gonzales MK, Sullivan JN, Nilubol N, Pacak K (2019) Postoperative management in patients with pheochromocytoma and paraganglioma. Cancers. https:\/\/doi.org\/10.3390\/cancers11070936","journal-title":"Cancers"},{"key":"2689_CR15","doi-asserted-by":"publisher","first-page":"e060839","DOI":"10.1136\/bmjopen-2022-060839","volume":"12","author":"N Rahadiani","year":"2022","unstructured":"Rahadiani N, Habiburrahman M, Abdullah M, Jeo WS, Stephanie M, Handjari DR, Krisnuhoni E (2022) Analysing 11 years of incidence trends, clinicopathological characteristics, and forecasts of colorectal cancer in young and old patients: a retrospective cross-sectional study in an Indonesian National referral hospital. BMJ Open 12:e060839. https:\/\/doi.org\/10.1136\/bmjopen-2022-060839","journal-title":"BMJ Open"},{"key":"2689_CR16","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa502","author":"J Jiang","year":"2020","unstructured":"Jiang J, Zhang J, Pang Y, Bechmann N, Li M, Monteagudo M, Calsina B, Gimenez-Roqueplo AP, N\u00f6lting S, Beuschlein F, Fassnacht M, Deutschbein T, Timmers H, \u00c5kerstr\u00f6m T, Crona J, Quinkler M, Fliedner SMJ, Liu Y, Guo J, Li X, Guo W, Hou Y, Wang C, Zhang L, Xiao Q, Liu L, Gao X, Burnichon N, Robledo M, Eisenhofer G (2020) Sino-European differences in the genetic landscape and clinical presentation of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 105. https:\/\/doi.org\/10.1210\/clinem\/dgaa502","journal-title":"J Clin Endocrinol Metab 105"},{"key":"2689_CR17","doi-asserted-by":"publisher","first-page":"e1835","DOI":"10.1210\/clinem\/dgac058","volume":"107","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li M, Pang Y, Wang C, Wu J, Cheng Z, Li X, Lu Z, Liu Y, Guo J, Chen X, He Y, Guan X, Xu X, Wang Y, Liu J, Guo W, Hou Y, Liu L, Jiang J, Gao X (2022) Genetic characteristics of incidental pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 107:e1835\u2013e1842. https:\/\/doi.org\/10.1210\/clinem\/dgac058","journal-title":"J Clin Endocrinol Metab"},{"key":"2689_CR18","doi-asserted-by":"publisher","DOI":"10.1530\/jme-22-0167","author":"A Casc\u00f3n","year":"2023","unstructured":"Casc\u00f3n A, Calsina B, Monteagudo M, Mellid S, D\u00edaz-Talavera A, Curr\u00e1s-Freixes M, Robledo M (2023) Genetic bases of pheochromocytoma and paraganglioma. J Mol Endocrinol 70. https:\/\/doi.org\/10.1530\/jme-22-0167","journal-title":"J Mol Endocrinol 70"},{"key":"2689_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","volume":"33","author":"O Mete","year":"2022","unstructured":"Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A (2022) Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas. Endocr Pathol 33:90\u2013114. https:\/\/doi.org\/10.1007\/s12022-022-09704-6","journal-title":"Endocr Pathol"},{"key":"2689_CR20","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1002\/jcsm.13071","volume":"13","author":"Y Pang","year":"2022","unstructured":"Pang Y, Li M, Jiang J, Chen X, Fu Y, Wang C, He Y, Zhao Y, Wang Y, Guan X, Zhang L, Xu X, Gan Y, Liu Y, Xie Y, Tang T, Wang J, Xie B, Liang Z, Chen D, Liu H, Chen C, Eisenhofer G, Liu L, Yi X, Chen BT (2022) Impact of body composition and genotype on haemodynamics during surgery for pheochromocytoma and paraganglioma. J Cachexia Sarcopenia Muscle 13:2843\u20132853. https:\/\/doi.org\/10.1002\/jcsm.13071","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2689_CR21","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00345-014-1397-z","volume":"33","author":"A de Fourmestraux","year":"2015","unstructured":"de Fourmestraux A, Salomon L, Abbou CC, Grise P (2015) Ten year experience of retroperitoneal laparoscopic resection for pheochromocytomas: a dual-centre study of 72 cases. World J Urol 33:1103\u20131107. https:\/\/doi.org\/10.1007\/s00345-014-1397-z","journal-title":"World J Urol"},{"key":"2689_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.urology.2016.09.004","volume":"98","author":"N Rao","year":"2016","unstructured":"Rao N, Ramachandran R, Tandon N, Singh P, Kumar R (2016) Surgical and hemodynamic outcomes in pheochromocytoma surgery: a prospective cohort study. Urology 98:103\u2013106. https:\/\/doi.org\/10.1016\/j.urology.2016.09.004","journal-title":"Urology"},{"key":"2689_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12957-019-1649-x","volume":"17","author":"W Zhu","year":"2019","unstructured":"Zhu W, Wang S, Du G, Liu H, Lu J, Yang W (2019) Comparison of retroperitoneal laparoscopic versus open adrenalectomy for large pheochromocytoma: a single-center retrospective study. World J Surg Oncol 17:111. https:\/\/doi.org\/10.1186\/s12957-019-1649-x","journal-title":"World J Surg Oncol"},{"key":"2689_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-021-00404-x","volume":"12","author":"M Li","year":"2021","unstructured":"Li M, Pamporaki C, Fliedner SMJ, Timmers H, N\u00f6lting S, Beuschlein F, Prejbisz A, Remde H, Robledo M, Bornstein SR, Lenders JWM, Eisenhofer G, Bechmann N (2021) Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion. Discov Oncol 12:9. https:\/\/doi.org\/10.1007\/s12672-021-00404-x","journal-title":"Discov Oncol"},{"key":"2689_CR25","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1210\/jc.2018-01707","volume":"104","author":"LM Gruber","year":"2019","unstructured":"Gruber LM, Hartman RP, Thompson GB, McKenzie TJ, Lyden ML, Dy BM, Young WF, Bancos I (2019) Pheochromocytoma characteristics and behavior differ depending on method of discovery. J Clin Endocr Metab 104:1386\u20131393. https:\/\/doi.org\/10.1210\/jc.2018-01707","journal-title":"J Clin Endocr Metab"},{"key":"2689_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","volume":"51","author":"AMA Berends","year":"2018","unstructured":"Berends AMA, Buitenwerf E, de Krijger RR, Veeger NJGM, van der Horst-Schrivers ANA, Links TP, Kerstens MN (2018) Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review. Eur J Intern Med 51:68\u201373. https:\/\/doi.org\/10.1016\/j.ejim.2018.01.015","journal-title":"Eur J Intern Med"},{"key":"2689_CR27","doi-asserted-by":"publisher","first-page":"E2251","DOI":"10.1210\/clinem\/dgaa965","volume":"106","author":"A Ebbehoj","year":"2021","unstructured":"Ebbehoj A, Stochholm K, Jacobsen SF, Trolle C, Jepsen P, Robaczyk MG, Rasmussen \u00c5K, Feldt-Rasmussen U, Thomsen RW, Sondergaard E, Poulsen PL (2021) Incidence and clinical presentation of pheochromocytoma and sympathetic paraganglioma: A Population-based study. J Clin Endocr Metab 106:E2251\u2013E2261. https:\/\/doi.org\/10.1210\/clinem\/dgaa965","journal-title":"J Clin Endocr Metab"},{"key":"2689_CR28","doi-asserted-by":"publisher","first-page":"E389","DOI":"10.1210\/clinem\/dgad401","volume":"109","author":"S Aggarwal","year":"2024","unstructured":"Aggarwal S, Prete A, Chortis V, Asia M, Sutcliffe RP, Arlt W, Ronchi CL, Karavitaki N, Ayuk J, Elhassan YS (2024) Pheochromocytomas most commonly present as adrenal incidentalomas: a large tertiary center experience. J Clin Endocrinol Metab 109:E389\u2013E396. https:\/\/doi.org\/10.1210\/clinem\/dgad401","journal-title":"J Clin Endocrinol Metab"},{"key":"2689_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101427","volume":"34","author":"S Cambos","year":"2020","unstructured":"Cambos S, Tabarin A (2020) Management of adrenal incidentalomas: working through uncertainty. Best Pract Res Clin Endocrinol Metab 34:101427. https:\/\/doi.org\/10.1016\/j.beem.2020.101427","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2689_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3803\/EnM.2023.1779","volume":"38","author":"SS Park","year":"2023","unstructured":"Park SS, Kim JH (2023) Recent updates on the management of adrenal incidentalomas. Endocrinol Metab 38:373\u2013380. https:\/\/doi.org\/10.3803\/EnM.2023.1779","journal-title":"Endocrinol Metab"},{"key":"2689_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.eprac.2024.11.004","volume":"31","author":"W Zhang","year":"2025","unstructured":"Zhang W, Yu J, Chen Y, Zhou Y, Cui Y, Li T, Wang Y, Ren W, Tong A, Li Y (2025) Glucose disorders in patients with pheochromocytoma\/paraganglioma: profile and influence effects in a large cohort with 705 patients. Endocr Pract 31:269\u2013277. https:\/\/doi.org\/10.1016\/j.eprac.2024.11.004","journal-title":"Endocr Pract"},{"key":"2689_CR32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1530\/ERC-22-0218","volume":"29","author":"M Araujo-Castro","year":"2022","unstructured":"Araujo-Castro M, Minguez Ojeda C, Garcia Centeno R, Lopez-Garcia MC, Lamas C, Hanzu FA, Mora M, Del Castillo Tous M, Rodriguez de Vera Gomez P, Parra Ramirez P, Alvarez-Escola C, Blanco Carrera C, Barahona San Millan R, Recasens M, Valdes N, Gracia Gimeno P, de Novoa M, Vicente P, Manjon A, Garcia Sanz L, Michalopoulou I, Calatayud T M (2022) Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas. Endocr Relat Cancer 29:645\u2013655. https:\/\/doi.org\/10.1530\/ERC-22-0218","journal-title":"Endocr Relat Cancer"},{"key":"2689_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1210\/jc.2010-1588","volume":"96","author":"G Eisenhofer","year":"2011","unstructured":"Eisenhofer G, Timmers HJ, Lenders JWM, Bornstein SR, Tiebel O, Mannelli M, King KS, Vocke CD, Linehan WM, Bratslavsky G, Pacak K (2011) Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J Clin Endocrinol Metab 96:375\u2013384. https:\/\/doi.org\/10.1210\/jc.2010-1588","journal-title":"J Clin Endocrinol Metab"},{"key":"2689_CR34","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1200\/Jco.2005.03.1484","volume":"23","author":"L Amar","year":"2005","unstructured":"Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard SP, Rohmer V, Sadoul JL, Strompf L, Schlumberger M, Bertagna X, Plouin PF, Jeunemaitre X, Gimenez-Roqueplo AP (2005) Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 23:8812\u20138818. https:\/\/doi.org\/10.1200\/Jco.2005.03.1484","journal-title":"J Clin Oncol"},{"key":"2689_CR35","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","volume":"86","author":"G Eisenhofer","year":"2001","unstructured":"Eisenhofer G, Walther MM, Huynh TT, Li ST, Bornstein SR, Vortmeyer A, Mannelli M, Goldstein DS, Linehan WM, Lenders JWM, Pacak K (2001) Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab 86:1999\u20132008. https:\/\/doi.org\/10.1210\/jcem.86.5.7496","journal-title":"J Clin Endocrinol Metab"},{"key":"2689_CR36","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1210\/jc.2004-1398","volume":"90","author":"L Amar","year":"2005","unstructured":"Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF (2005) Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab 90:2110\u20132116. https:\/\/doi.org\/10.1210\/jc.2004-1398","journal-title":"J Clin Endocrinol Metab"},{"key":"2689_CR37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1210\/clinem\/dgac563","volume":"108","author":"M Li","year":"2023","unstructured":"Li M, Prodanov T, Meuter L, Kerstens MN, Bechmann N, Prejbisz A, Remde H, Timmers H, Nolting S, Talvacchio S, Berends AMA, Fliedner S, Robledo M, Lenders JWM, Pacak K, Eisenhofer G, Pamporaki C (2023) Recurrent disease in patients with sporadic pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 108:397\u2013404. https:\/\/doi.org\/10.1210\/clinem\/dgac563","journal-title":"J Clin Endocrinol Metab"},{"key":"2689_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41574-023-00926-0","volume":"20","author":"D Taieb","year":"2024","unstructured":"Taieb D, Nolting S, Perrier ND, Fassnacht M, Carrasquillo JA, Grossman AB, Clifton-Bligh R, Wanna GB, Schwam ZG, Amar L, Bourdeau I, Casey RT, Crona J, Deal CL, Del Rivero J, Duh QY, Eisenhofer G, Fojo T, Ghayee HK, Gimenez-Roqueplo AP, Gill AJ, Hicks R, Imperiale A, Jha A, Kerstens MN, de Krijger RR, Lacroix A, Lazurova I, Lin FI, Lussey-Lepoutre C, Maher ER, Mete O, Naruse M, Nilubol N, Robledo M, Sebag F, Shah NS, Tanabe A, Thompson GB, Timmers H, Widimsky J, Young WJ Jr, Meuter L, Lenders JWM, Pacak K (2024) Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert consensus statement. Nat Rev Endocrinol 20:168\u2013184. https:\/\/doi.org\/10.1038\/s41574-023-00926-0","journal-title":"Nat Rev Endocrinol"},{"key":"2689_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2024.101928","volume":"38","author":"J Jiang","year":"2024","unstructured":"Jiang J, Liu Y (2024) Recent discoveries of Sino-Caucasian differences in the genetics of phaeochromocytomas and paragangliomas. Best Pract Res Clin Endocrinol Metab 38:101928. https:\/\/doi.org\/10.1016\/j.beem.2024.101928","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2689_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS, Cancer Genome Atlas Research N, Pacak K, Nathanson KL, Wilkerson MD (2017) Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31:181\u2013193. https:\/\/doi.org\/10.1016\/j.ccell.2017.01.001","journal-title":"Cancer Cell"},{"key":"2689_CR41","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-23-0230","author":"M Li","year":"2023","unstructured":"Li M, Richter S, Mohr H, Drukewitz S, Poser I, Stanke D, Calsina B, Martinez-Montes AM, Quinkler M, Timmers H, Nolting S, Beuschlein F, Remde H, Opocher G, Rapizzi E, Pacak K, Pamporaki C, Robledo M, Liu L, Jiang J, Bornstein SR, Eisenhofer G, Fliedner SMJ, Bechmann N (2023) Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas. Endocr Relat Cancer 30. https:\/\/doi.org\/10.1530\/ERC-23-0230","journal-title":"Endocr Relat Cancer 30"},{"key":"2689_CR42","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1097\/Js9.0000000000001995","volume":"111","author":"MH Li","year":"2025","unstructured":"Li MH, Zhang J, Pang YX, He Y, Shen YT, Wang J, Xu XW, Liu JH, Cheng K, Li Z, Liu YJ, Gao X, Eisenhofer G, Jiang JJ, Liu LF (2025) Genetic background and intraoperative haemodynamic instability in patients with pheochromocytoma and paraganglioma: a multicentre retrospective study. Int J Surg 111:913\u2013919. https:\/\/doi.org\/10.1097\/Js9.0000000000001995","journal-title":"Int J Surg"},{"key":"2689_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/anae.15535","volume":"77","author":"AJ Wickham","year":"2022","unstructured":"Wickham AJ, Highton DT, Clark S, Fallaha D, Wong DJN, Martin DS, Research, Audit Federation of T (2022) Treatment threshold for intra-operative hypotension in clinical practice-a prospective cohort study in older patients in the UK. Anaesthesia 77:153\u2013163. https:\/\/doi.org\/10.1111\/anae.15535","journal-title":"Anaesthesia"},{"key":"2689_CR44","doi-asserted-by":"publisher","unstructured":"Holscher I, Engelsman AF, Dreijerink KMA, Hollmann MW, van den Berg TJ, Nieveen, van Dijkum EJM (2024) Omitting the Escalating Dosage of Alpha-adrenergic Blockade Before Pheochromocytoma Resection: Implementation of a Treatment Strategy in Discordance With Current Guidelines. Ann Surg 280:817\u2013824. https:\/\/doi.org\/10.1097\/SLA.0000000000006493","DOI":"10.1097\/SLA.0000000000006493"},{"key":"2689_CR45","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/cen.14557","volume":"95","author":"T Takeda","year":"2021","unstructured":"Takeda T, Hakozaki K, Yanai Y, Masuda T, Yasumizu Y, Tanaka N, Matsumoto K, Morita S, Kosaka T, Mizuno R, Kurihara I, Asanuma H, Itoh H, Oya M (2021) Risk factors for haemodynamic instability and its prolongation during laparoscopic adrenalectomy for pheochromocytoma. Clin Endocrinol (Oxf) 95:716\u2013726. https:\/\/doi.org\/10.1111\/cen.14557","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2689_CR46","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1210\/clinem\/dgz188","volume":"105","author":"E Buitenwerf","year":"2020","unstructured":"Buitenwerf E, Osinga TE, Timmers H, Lenders JWM, Feelders RA, Eekhoff EMW, Haak HR, Corssmit EPM, Bisschop P, Valk GD, Veldman RG, Dullaart RPF, Links TP, Voogd MF, Wietasch G, Kerstens MN (2020) Efficacy of alpha-blockers on hemodynamic control during pheochromocytoma resection: a randomized controlled trial. J Clin Endocrinol Metab 105:2381\u20132391. https:\/\/doi.org\/10.1210\/clinem\/dgz188","journal-title":"J Clin Endocrinol Metab"},{"key":"2689_CR47","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1097\/JS9.0000000000001995","volume":"111","author":"M Li","year":"2024","unstructured":"Li M, Zhang J, Pang Y, He Y, Shen Y, Wang J, Xu X, Liu J, Cheng K, Li Z, Liu Y, Gao X, Eisenhofer G, Jiang J, Liu L (2024) Genetic background and intraoperative haemodynamic instability in patients with pheochromocytoma and paraganglioma: a multicenter retrospective study. Int J Surg 111:913\u2013919. https:\/\/doi.org\/10.1097\/JS9.0000000000001995","journal-title":"Int J Surg"},{"key":"2689_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2024.101956","volume":"38","author":"X Guan","year":"2024","unstructured":"Guan X, Li M, Pang Y, He Y, Wang J, Xu X, Cheng K, Li Z, Liu L (2024) Recent advances in algorithms predicting hemodynamic instability undergoing surgery for phaeochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab 38:101956. https:\/\/doi.org\/10.1016\/j.beem.2024.101956","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2689_CR49","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/bja\/aew392","volume":"118","author":"H Groeben","year":"2017","unstructured":"Groeben H, Nottebaum BJ, Alesina PF, Traut A, Neumann HP, Walz MK (2017) Perioperative alpha-receptor blockade in phaeochromocytoma surgery: an observational case series. Br J Anaesth 118:182\u2013189. https:\/\/doi.org\/10.1093\/bja\/aew392","journal-title":"Br J Anaesth"},{"key":"2689_CR50","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.surg.2014.08.022","volume":"156","author":"L Brunaud","year":"2014","unstructured":"Brunaud L, Boutami M, Nguyen-Thi PL, Finnerty B, Germain A, Weryha G, Fahey TJ 3rd, Mirallie E, Bresler L, Zarnegar R (2014) Both preoperative alpha and calcium channel Blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma. Surgery 156:1410\u20131417 discussion1417-1418. https:\/\/doi.org\/10.1016\/j.surg.2014.08.022","journal-title":"Surgery"},{"key":"2689_CR51","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.surg.2012.08.023","volume":"152","author":"HK Siddiqi","year":"2012","unstructured":"Siddiqi HK, Yang HY, Laird AM, Fox AC, Doherty GM, Miller BS, Gauger PG (2012) Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas. Surgery 152:1027\u20131036. https:\/\/doi.org\/10.1016\/j.surg.2012.08.023","journal-title":"Surgery"},{"key":"2689_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2044.2005.04156.x","volume":"60","author":"G Lebuffe","year":"2005","unstructured":"Lebuffe G, Dosseh ED, Tek G, Tytgat H, Moreno S, Tavernier B, Vallet B, Proye CA (2005) The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anaesthesia 60:439\u2013444. https:\/\/doi.org\/10.1111\/j.1365-2044.2005.04156.x","journal-title":"Anaesthesia"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02689-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02689-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02689-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:46:42Z","timestamp":1769496402000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02689-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["2689"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02689-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflict of interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study adhered to the Declaration of Helsinki and Good Clinical Practice guidelines. Patients provided written informed consent for the utilization of their data and samples in clinical studies, in accordance with approvals from the respective Ethics Committee or Institutional Review Board (IRB) approvals in Xiangya Hospital, Central South University (No. 201905133) and Zhongshan Hospital, Fudan University (No. B2019-007R).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\u00a0<!--Emphasis Type='Bold' removed-->and informed consent"}}]}}